Checkmate Pharmaceuticals, Inc. (CMPI)

Exchange NASDAQ
10.5


Currency in USD (Disclaimer)
Volume:
Day's Range:

CMPI Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-05-31 POWELL MICHAEL director 0.0 D-Return D 30,000.0 10.95 328,500.00
2022-05-31 Isacoff Oren director 0.0 D-Return D 20,000.0 10.95 219,000.00
2022-05-31 Flaherty Keith T. director 0.0 D-Return D 22,736.0 2.62 59,568.32
2022-05-31 Colabuono Peter director 0.0 D-Return D 20,000.0 10.95 219,000.00
2022-05-31 Yan Joy director 0.0 D-Return D 20,061.0 3.12 62,590.32
2022-05-31 Wooldridge James officer: Chief Medical Officer 0.0 D-Return D 95,916.0 2.62 251,299.92
2022-05-31 Dolski Robert officer: Chief Financial Officer 0.0 D-Return D 150,000.0 14.84 2,226,000.00
2022-05-31 Fuhrman Alan director 0.0 D-Return D 22,736.0 2.62 59,568.32
2022-05-31 Wigginton Jon Marc director 0.0 D-Return D 20,061.0 2.19 43,933.59
2022-05-31 BASH ALAN director, officer: Chief Executive Officer 0.0 D-Return D 575,000.0 2.99 1,719,250.00
2022-05-16 venBio Global Strategic Fund II L.P. 10 percent owner 2,155,930.0 S-Sale D 95,800.0 10.45 1,001,100.42
2022-05-13 venBio Global Strategic Fund II L.P. 10 percent owner 2,251,730.0 S-Sale D 35,850.0 10.45 374,464.01
2022-05-12 venBio Global Strategic Fund II L.P. 10 percent owner 2,287,580.0 S-Sale D 124,525.0 10.39 1,294,312.85
2022-05-11 venBio Global Strategic Fund II L.P. 10 percent owner 2,412,105.0 S-Sale D 17,700.0 10.38 183,641.04
2022-05-10 venBio Global Strategic Fund II L.P. 10 percent owner 2,429,805.0 S-Sale D 18,676.0 10.38 193,869.95
2022-05-09 venBio Global Strategic Fund II L.P. 10 percent owner 2,448,481.0 S-Sale D 17,600.0 10.37 182,582.40
2022-05-06 venBio Global Strategic Fund II L.P. 10 percent owner 2,466,081.0 S-Sale D 48,334.0 10.37 501,233.25
2022-05-05 venBio Global Strategic Fund II L.P. 10 percent owner 2,514,415.0 S-Sale D 20,743.0 10.37 215,104.91
2022-05-04 venBio Global Strategic Fund II L.P. 10 percent owner 2,535,158.0 S-Sale D 37,500.0 10.37 388,923.75
2022-05-03 venBio Global Strategic Fund II L.P. 10 percent owner 2,572,658.0 S-Sale D 79,475.0 10.37 824,433.91
2022-05-02 venBio Global Strategic Fund II L.P. 10 percent owner 2,652,133.0 S-Sale D 153,700.0 10.38 1,595,974.69
2022-04-29 venBio Global Strategic Fund II L.P. 10 percent owner 2,805,833.0 S-Sale D 69,230.0 10.38 718,662.78
2022-04-28 venBio Global Strategic Fund II L.P. 10 percent owner 2,875,063.0 S-Sale D 73,400.0 10.38 761,936.04
2022-04-27 venBio Global Strategic Fund II L.P. 10 percent owner 2,948,463.0 S-Sale D 47,396.0 10.38 491,979.96
2022-04-26 venBio Global Strategic Fund II L.P. 10 percent owner 2,995,859.0 S-Sale D 64,683.0 10.38 671,558.31
2022-04-25 venBio Global Strategic Fund II L.P. 10 percent owner 3,060,542.0 S-Sale D 27,668.0 10.39 287,404.12
2022-04-22 venBio Global Strategic Fund II L.P. 10 percent owner 3,088,210.0 S-Sale D 37,430.0 10.39 388,834.07
2022-04-21 venBio Global Strategic Fund II L.P. 10 percent owner 3,125,640.0 S-Sale D 62,200.0 10.38 645,866.14
2022-04-20 venBio Global Strategic Fund II L.P. 10 percent owner 3,187,840.0 S-Sale D 85,611.0 10.39 889,387.00
2022-04-19 venBio Global Strategic Fund II L.P. 10 percent owner 3,273,451.0 S-Sale D 399,923.0 10.42 4,165,238.04
2022-03-01 BASH ALAN director, officer: Chief Executive Officer 575,000.0 A-Award A 575,000.0 2.99 1,719,250.00
2022-02-25 Novo Holdings A/S 10 percent owner 2,161,990.0 S-Sale D 300.0 2.70 810.96
2022-02-24 Novo Holdings A/S 10 percent owner 2,162,290.0 S-Sale D 5,990.0 2.83 16,978.65
2022-02-23 Novo Holdings A/S 10 percent owner 2,168,280.0 S-Sale D 1,820.0 2.90 5,277.45
2022-01-30 Wigginton Jon Marc director 20,061.0 A-Award A 20,061.0 2.19 43,933.59
2022-01-27 Wooldridge James officer: Chief Medical Officer 101,180.0 A-Award A 101,180.0 2.05 207,419.00
2022-01-27 Dolski Robert officer: Chief Financial Officer 101,180.0 A-Award A 101,180.0 2.05 207,419.00
2021-12-16 Yan Joy director 20,061.0 A-Award A 20,061.0 3.12 62,590.32
2021-10-27 Fuhrman Alan director, officer: Interim President and Chief Executive Officer 246,671.0 A-Award A 246,671.0 3.93 969,417.03
2021-08-09 POWELL MICHAEL director 30,000.0 A-Award A 30,000.0 5.19 155,700.00
2021-08-04 Dolski Robert officer: Chief Financial Officer 27,300.0 A-Award A 27,300.0 5.09 138,957.00
2021-08-04 Wooldridge James officer: Chief Medical Officer 27,300.0 A-Award A 27,300.0 5.09 138,957.00
2021-08-04 Labinger Barry director, officer: President and CEO 85,950.0 A-Award A 85,950.0 5.09 437,485.50
2021-08-04 Chaudhary Kleem officer: Chief Business Officer 27,300.0 A-Award A 27,300.0 5.09 138,957.00
2021-06-18 Krieg Arthur M officer: Chief Scientific Officer 815,734.0 P-Purchase A 7,224.0 6.04 43,632.96
2021-06-16 Krieg Arthur M officer: Chief Scientific Officer 808,510.0 P-Purchase A 3,578.0 6.18 22,112.04
2021-06-16 Colabuono Peter director 10,030.0 A-Award A 10,030.0 6.27 62,888.10
2021-06-16 Isacoff Oren director 10,030.0 A-Award A 10,030.0 6.27 62,888.10
2021-06-16 Flaherty Keith T. director 10,030.0 A-Award A 10,030.0 6.27 62,888.10
2021-06-16 Fuhrman Alan director 10,030.0 A-Award A 10,030.0 6.27 62,888.10
2021-06-16 POWELL MICHAEL director, 10 percent owner 10,030.0 A-Award A 10,030.0 6.27 62,888.10
2021-05-28 Krieg Arthur M officer: Chief Scientific Officer 0.0 J-Other D 68,457.0 0.00 0.00
2021-05-18 Krieg Arthur M officer: Chief Scientific Officer 804,932.0 P-Purchase A 25,001.0 6.97 174,256.97
2021-03-29 Krieg Arthur M officer: Chief Scientific Officer 764,179.0 P-Purchase A 17,468.0 10.94 191,099.92
2021-03-29 Krieg Arthur M officer: Chief Scientific Officer 779,931.0 P-Purchase A 15,752.0 11.40 179,572.80
2021-03-26 Krieg Arthur M officer: Chief Scientific Officer 746,711.0 P-Purchase A 3,484.0 12.15 42,330.60
2021-03-25 Krieg Arthur M officer: Chief Scientific Officer 743,227.0 P-Purchase A 10,036.0 12.35 123,944.60
2021-03-04 Wooldridge James officer: Chief Medical Officer 54,600.0 A-Award A 54,600.0 13.50 737,100.00
2021-02-26 Chaudhary Kleem officer: Chief Business Officer 8,000.0 M-Exempt A 2,000.0 2.62 5,240.00
2021-02-26 Chaudhary Kleem officer: Chief Business Officer 97,508.0 M-Exempt D 2,000.0 2.62 5,240.00
2021-01-27 Krieg Arthur M officer: Chief Scientific Officer 733,191.0 P-Purchase A 1,701.0 13.05 22,198.05
2021-01-19 Krieg Arthur M officer: Chief Scientific Officer 731,490.0 P-Purchase A 500.0 13.09 6,545.00
2021-01-14 Chaudhary Kleem officer: Chief Business Officer 6,000.0 M-Exempt A 2,000.0 2.62 5,240.00
2021-01-14 Chaudhary Kleem officer: Chief Business Officer 99,508.0 M-Exempt D 2,000.0 2.62 5,240.00
2020-12-29 Krieg Arthur M officer: Chief Scientific Officer 730,990.0 P-Purchase A 443.0 14.16 6,272.88
2020-12-22 Krieg Arthur M officer: Chief Scientific Officer 730,547.0 P-Purchase A 5,103.0 14.64 74,707.92
2020-12-22 Chaudhary Kleem officer: Chief Business Officer 4,000.0 M-Exempt A 4,000.0 2.62 10,480.00
2020-12-22 Chaudhary Kleem officer: Chief Business Officer 101,508.0 M-Exempt D 4,000.0 2.62 10,480.00
2020-12-16 Krieg Arthur M officer: Chief Scientific Officer 725,444.0 P-Purchase A 4,805.0 14.62 70,249.10
2020-12-15 Krieg Arthur M officer: Chief Scientific Officer 720,639.0 P-Purchase A 42.0 14.49 608.58
2020-11-10 Isacoff Oren director 20,000.0 A-Award A 20,000.0 10.95 219,000.00
2020-11-10 POWELL MICHAEL director, 10 percent owner 30,000.0 A-Award A 30,000.0 10.95 328,500.00
2020-11-10 Colabuono Peter director 20,000.0 A-Award A 20,000.0 10.95 219,000.00
2020-08-11 POWELL MICHAEL director, 10 percent owner 3,473,374.0 C-Conversion A 3,473,374.0 0.00 0.00
2020-08-11 POWELL MICHAEL director, 10 percent owner 3,606,707.0 P-Purchase A 133,333.0 15.00 1,999,995.00
2020-08-11 POWELL MICHAEL director, 10 percent owner 0.0 C-Conversion D 12,500,000.0 0.00 0.00
2020-08-11 venBio Global Strategic Fund II L.P. 10 percent owner 3,473,374.0 C-Conversion A 3,473,374.0 0.00 0.00
2020-08-11 venBio Global Strategic Fund II L.P. 10 percent owner 3,673,374.0 P-Purchase A 200,000.0 15.00 3,000,000.00
2020-08-11 venBio Global Strategic Fund II L.P. 10 percent owner 0.0 C-Conversion D 12,500,000.0 0.00 0.00
2020-08-11 Novo Holdings A/S 10 percent owner 1,670,100.0 C-Conversion A 1,670,100.0 0.00 0.00
2020-08-11 Novo Holdings A/S 10 percent owner 2,170,100.0 P-Purchase A 500,000.0 15.00 7,500,000.00
2020-08-11 Novo Holdings A/S 10 percent owner 0.0 C-Conversion D 12,487,512 0.00 0.00
2020-08-06 Wooldridge James officer: Chief Medical Officer 150,818.0 A-Award A 150,818.0 15.00 2,262,270.00
2020-08-06 Labinger Barry director, officer: President and CEO 445,819.0 A-Award A 445,819.0 15.00 6,687,285.00
2020-08-06 Chaudhary Kleem officer: Chief Business Officer 141,226.0 A-Award A 141,226.0 15.00 2,118,390.00
2020-08-06 Brennan Karen officer: Chief Operating Officer 53,496.0 A-Award A 53,496.0 15.00 802,440.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.